Previous Close | 3.4600 |
Open | 3.4600 |
Bid | 3.2000 |
Ask | 5.4000 |
Strike | 2.50 |
Expire Date | 2024-08-16 |
Day's Range | 3.4600 - 3.4600 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
On June 10, 2024, Julie Mchugh, Director at Ironwood Pharmaceuticals Inc (NASDAQ:IRWD), executed a sale of 22,766 shares of the company.
On June 7, 2024, Catherine Moukheibir, a Director at Ironwood Pharmaceuticals Inc (NASDAQ:IRWD), executed a sale of 80,000 shares of the company.
BOSTON, May 30, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m. ET at the Marriott Marquis in New York City.